TransMedics Group (TMDX)
(Delayed Data from NSDQ)
$168.06 USD
+1.41 (0.85%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $168.81 +0.75 (0.45%) 7:58 PM ET
1-Strong Buy of 5 1
F Value A Growth B Momentum C VGM
Balance Sheet
Fiscal Year End for TransMedics Group, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 395 | 201 | 92 | 126 | 81 |
Receivables | 64 | 28 | 6 | 7 | 7 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 44 | 21 | 15 | 12 | 11 |
Other Current Assets | 8 | 3 | 5 | 2 | 2 |
Total Current Assets | 511 | 252 | 119 | 147 | 100 |
Net Property & Equipment | 174 | 19 | 10 | 5 | 5 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 14 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 1 | 1 | 1 | 1 | 1 |
Total Assets | 706 | 277 | 135 | 152 | 105 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 13 | 3 | 7 | 1 | 7 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 38 | 19 | 16 | 10 | 8 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 2 | 0 | 0 | 0 | 1 |
Total Current Liabilities | 55 | 24 | 23 | 12 | 16 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 447 | 0 | 0 | 0 | 0 |
Long-Term Debt | 59 | 59 | 35 | 35 | 34 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 2 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 569 | 90 | 67 | 48 | 51 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 641 | 666 | 510 | 502 | 424 |
Capital Surplus | 0 | 0 | 0 | 0 | 0 |
Retained Earnings | -504 | -479 | -442 | -398 | -369 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 137 | 187 | 68 | 104 | 55 |
Total Liabilities & Shareholder's Equity | 706 | 277 | 135 | 152 | 105 |
Total Common Equity | 137 | 187 | 68 | 104 | 55 |
Shares Outstanding | 32.60 | 31.90 | 27.70 | 27.10 | 21.10 |
Book Value Per Share | 4.21 | 5.87 | 2.45 | 3.83 | 2.59 |
Fiscal Year End for TransMedics Group, Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 363 | 350 | 395 | 427 | 582 |
Receivables | 81 | 82 | 64 | 61 | 48 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 49 | 49 | 44 | 39 | 31 |
Other Current Assets | 17 | 8 | 8 | 10 | 2 |
Total Current Assets | 509 | 488 | 511 | 537 | 663 |
Net Property & Equipment | 229 | 214 | 174 | 131 | 20 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 14 | 14 | 14 | 14 | 0 |
Deposits & Other Assets | 1 | 1 | 1 | 1 | 1 |
Total Assets | 759 | 724 | 706 | 689 | 690 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 13 | 9 | 13 | 13 | 7 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 38 | 37 | 38 | 32 | 23 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 1 | 2 | 2 | 3 | 0 |
Total Current Liabilities | 54 | 50 | 55 | 49 | 32 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 449 | 448 | 447 | 446 | 446 |
Long-Term Debt | 59 | 59 | 59 | 59 | 59 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 569 | 564 | 569 | 563 | 545 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 669 | 651 | 641 | 634 | 628 |
Capital Surplus | 0 | 0 | 0 | 0 | 0 |
Retained Earnings | -479 | -492 | -504 | -508 | -482 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 190 | 159 | 137 | 126 | 145 |
Total Liabilities & Shareholder's Equity | 759 | 724 | 706 | 689 | 690 |
Total Common Equity | 190 | 159 | 137 | 126 | 145 |
Shares Outstanding | 33.30 | 32.70 | 32.60 | 32.60 | 32.50 |
Book Value Per Share | 5.70 | 4.88 | 4.21 | 3.88 | 4.47 |